A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - Related Studies

A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

This study is currently recruiting participants.

Study NCT00566397. Last updated on October 30, 2008. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Alzheimer's Disease

2	Additional conditions recognized in this trial
		Alzheimer Disease

3	More general conditions related to this trial
		Brain Diseases
		Central Nervous System Diseases
		Delirium, Dementia, Amnestic, Cognitive Disorders
		Dementia
		Mental Disorders
		Nervous System Diseases
		Neurodegenerative Diseases
		Tauopathies

4	Interventions listed in this trial
		PF-04494700
		Placebo

5	Sponsors listed in this trial
		Pfizer
		Alzheimer's Disease Cooperative Study (ADCS)